Evolocumab Alters Vascular Function in Patients With Cardiovascular Disease

被引：0
|
作者：
Kannenkeril, Dennis
Bosch, Agnes
Striepe, Kristina
Berner, Laura
Pietschner, Robert
Kolwelter, Julie
Ott, Christian
Schiffer, Mario
Achenbach, Stephan
Schmieder, Roland E.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13958
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease (vol 2, pg 1069, 2017)
    Fonarow, G. C.
    Keech, A. C.
    Pedersen, T. R.
    JAMA CARDIOLOGY, 2017, 2 (10) : 1170 - 1170
  • [42] Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
    Fonarow, Gregg C.
    van Hout, Ben
    Villa, Guillermo
    Arellano, Jorge
    Lindgren, Peter
    JAMA CARDIOLOGY, 2019, 4 (07) : 691 - 695
  • [43] Inhibition of BKCa negatively alters cardiovascular function
    Patel, Nishi H.
    Johannesen, Justin
    Shah, Kajol
    Goswami, Sumanta K.
    Patel, Neel J.
    Ponnalagu, Devasena
    Kohut, Andrew R.
    Singh, Harpreet
    PHYSIOLOGICAL REPORTS, 2018, 6 (12):
  • [44] COST-EFFECTIVENESS OF EVOLOCUMAB IN PATIENTS WITH HIGH CARDIOVASCULAR RISK IN SPAIN
    Villa, G.
    Lothgren, M.
    Kutikova, L.
    Lindgren, P.
    Gandra, S. R.
    Fonarow, G. C.
    Sorio, F.
    Masana, L.
    Bayes-Genis, A.
    van Hout, B.
    VALUE IN HEALTH, 2016, 19 (07) : A651 - A652
  • [45] Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk
    Rajtar-Salwa, Renata
    Bobrowska, Beata
    Socha, Sylwia
    Dziewierz, Artur
    Siudak, Zbigniew
    Batko, Jakub
    Bartus, Stanislaw
    Krawczyk-Ozog, Agata
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [46] Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain
    Villa, Guillermo
    Lothgren, Mickael
    Kutikova, Lucie
    Lindgren, Peter
    Gandra, Shravanthi R.
    Fonarow, Gregg C.
    Sorio, Francesc
    Masana, Lluis
    Bayes-Genis, Antoni
    van Hout, Ben
    CLINICAL THERAPEUTICS, 2017, 39 (04) : 771 - 786
  • [47] Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease
    Moser, David J.
    Robinson, Robert G.
    Hynes, Stephanie M.
    Reese, Rebecca L.
    Arndt, Stephan
    Paulsen, Jane S.
    Haynes, William G.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) : 141 - 146
  • [48] Cardiovascular Disease and Marrow Vascular Markers in Patients with Myeloid Malignancies
    Sanchez-Petitto, Gabriela
    Kallen, Michael
    Koka, Madhurima
    Goloubeva, Olga
    Masur, Jack
    An, Max
    Childress, James
    Iqbal, Tahreem
    Safwan, Muhammad
    Lawson, Justin
    Barr, Brian
    Duong, Vu H.
    Law, Jennie Y.
    Emadi, Ashkan
    Baer, Maria R.
    Niyongere, Sandrine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S350 - S351
  • [49] Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial
    Gajendragadkar, Parag R.
    Hubsch, Annette
    Maeki-Petaejae, Kaisa M.
    Serg, Martin
    Wilkinson, Ian B.
    Cheriyan, Joseph
    PLOS ONE, 2014, 9 (06):
  • [50] Regular exercise habits and vascular endothelium function in patients with cardiovascular diseases
    Meguro, K.
    Iidaka, T.
    Nakata, M.
    Yamashita, T.
    Chinen, T.
    Fujita, M.
    Kikuchi, T.
    Keida, T.
    Ohira, H.
    EUROPEAN HEART JOURNAL, 2014, 35 : 730 - 731
12345